Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
Laurent Peyrin‐Biroulet(Inserm), Joannie Ruel(Centre Hospitalier Universitaire de Sherbrooke), Mark S. Silverberg(Mount Sinai Hospital), Péter L. Lakatos(Semmelweis University), Remo Panaccione(University of Calgary), Suneeta Krishnareddy(New Leaders), Stephen B. Hanauer(Northwestern University), Gionata Fiorino(New Leaders), Bruce E. Sands(Icahn School of Medicine at Mount Sinai), Robert H. Riddell(Mount Sinai Hospital), Philippe Marteau(Université Paris Cité), Marla C. Dubinsky(New Leaders), Jaap Stoker(University of Amsterdam), Iris Dotan(Tel Aviv University), William J. Sandborn(Mayo Clinic), Sarah O’Donnell(Mount Sinai Hospital), Richard B. Gearry(New Leaders), Mark Samaan(New Leaders), Julián Panés(Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas), Gert Van Assche(KU Leuven), Benjamin Pariente(New Leaders), Silvio Danese(Università Cattolica del Sacro Cuore), Brian G. Feagan(Western University), David T. Rubin(University of California System), Willem A. Bemelman(Amsterdam University Medical Centers), Edward V. Loftus(Mayo Clinic), Geert D’Haens(Amsterdam UMC Location University of Amsterdam), Guillaume Bouguen(Foie, Métabolisme, Cancer), Shawn Winer(University of Toronto), Simon Travis(John Radcliffe Hospital), Íngrid Ordás(New Leaders), Corey A. Siegel(Dartmouth–Hitchcock Medical Center), Travis B. Murdoch(Mount Sinai Hospital), Pia Munkholm(University of Copenhagen), Walter Reinisch(Medical University of Vienna), Robert V. Bryant(New Leaders), S Schreiber(New Leaders)
Cited by 1,837
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Crohn's disease
|The Lancet|2012|2.1k
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k